Close

Bristol-Myers Squibb (BMY) Announces Statistically Significant Data from Opdivo Phase 3 in Squamous Cell Carcinoma

Go back to Bristol-Myers Squibb (BMY) Announces Statistically Significant Data from Opdivo Phase 3 in Squamous Cell Carcinoma